Healthy adult
Conditions
Interventions
Intake of test food containing 500mg of ONO-SR/PS for 4 weeks
Intake of test food containing 1,000mg of ONO-SR/PS for 4 weeks
Sponsors
EP Mediate Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Healthy males and females from 20 to 64 years of age (2) BMI 18.5 or more and less than 25 (3) Subjects to measured ECG and stress/fatigue who are appliciable to following items Height Male:155-185cm, Female:150-185cm Bust Male:79-104cm, Female:79-102cm and bust less than E cup Waist Male:less than 94cm, Female:less than 88cm
Exclusion criteria
Exclusion criteria: (1)Subjects who constantly use health food richly containing DHA, EPA, astaxanthin and shark liver oil involvement ingredient more than 1 times a week (2)Subjects who having habit of fish and shellfish including fish roe more than 4 times a week (3)Subjects having possibilities for emerging allergy relates to the study (e.g., fish, prawns, crab, and spawn) (4)Subjects who having skin disease (e.g., contact dermatitis, and lacerations) , or sensitive skin on the upper arm or upper body (5)Subjects having a disease requiring treatment or a history of serious diseases (e.g., diabetes, liver disease, kidney disease, heart disease, endocrine disease, metabolic diseases, malignancy, and cancer) for which medication was required including implanted medical device such as cardiac pacemaker, and medical equipment necessary to sustain life such as a monitoring system (6)Subjects who have diseases requiring medication, and treatment except dry eye and cavity protection, or have a history of serious diseases that required medication treatment (7)Subjects who are judges as unsuitable for the study bases on the result of clinical and physical examination on preliminary examination (8)Subjects who are judges as unsuitable for the study based on the results of lifestyle questionnaire (9)Subjects judged as unsuitable for the study based on the results of clinical examination or cardiopulmonary abnormality in the past (10)Subjects who are participating in other clinical research at the start of this study (11)Subjects who are becoming pregnant or intend to become pregnant (12)Subjects judged as unsuitable for the study by the investigator for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hematologic test, Blood biochemistry test, Urine test, Blood pressure/pulsation, Weight/body mass index, Medical Interview, before and 4 weeks after intake and 2 weeks after the end of intake period and Adverse events through the study | — |
Countries
Japan
Contacts
Public ContactTamaki Furuhata
EP Mediate Co., Ltd. Foods Department, Trial Planning Section 1
Outcome results
None listed